Immunohistochemical Subclassification of Peripheral T Cell Lymphomas-Not Otherwise Specified.

Area of Science:

• Hematology
• Oncology
• Immunopathology

Background:

• Peripheral T cell lymphomas-not otherwise specified (PTCL-NOS) represent a diverse group of mature T cell lymphomas lacking specific subtype classification.
• Gene expression profiling has identified two biological variants: PTCLGATA3 and PTCLTBX21.
• Accurate subclassification is crucial for understanding prognosis and guiding treatment strategies in PTCL-NOS.

Purpose of the Study:

• To subclassify PTCL-NOS using immunohistochemistry (IHC).
• To investigate the prognostic implications of these subtypes.
• To correlate IHC findings with morphological and proliferation index characteristics.

Main Methods:

• A descriptive study analyzed 39 diagnosed cases of PTCL-NOS over a 10-year period (2013-2022).
• Immunohistochemistry utilized GATA3 and CCR4 for PTCLGATA3, and TBX21 and CXCR3 for PTCLTBX21.
• Minimum follow-up of 6 months was ensured for all cases.

Main Results:

• The PTCLGATA3 subtype constituted 44% of the subclassified PTCL-NOS cases.
• PTCLGATA3 cases exhibited monomorphic morphology and a high ki67 proliferation index, correlating with a worse outcome.
• In contrast, PTCLTBX21 cases displayed heterogeneous morphology and a low ki67 index.

Conclusions:

• Subcategorization of PTCL-NOS using IHC markers facilitates disease stratification.
• This IHC-based approach aids in identifying cases with more aggressive behavior at diagnosis.
• The findings support the utility of IHC for refining PTCL-NOS classification and predicting patient prognosis.